e-ISSN 1726-6890
p-ISSN 1735-0328
Citation data
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
12 resultsUpdated September 21, 2026
1
Investigating the effects of olanzapine on appetite and weight in patients with cancer in a systematic review
Discover Oncology
December 2026
Renaux Torres M.C.
Open Access
2
Olanzapine (10 mg vs 5 mg vs 2.5 mg) for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) — a systematic review and network meta-analysis
Supportive Care in Cancer
August 2026
Chow R.
Open Access
3
Mirtazapine revisited: new therapeutic perspectives and formulation advances
Naunyn Schmiedeberg S Archives of Pharmacology
January 2026
Mehra A.
4
Effects of olanzapine in the improvement of body weight and appetite in patients with cancer or receiving chemotherapy: a systematic review and meta-analysis
European Journal of Clinical Pharmacology
January 2025
Yuan L.
5
6
The emerging emetogenicity of trifluridine/tipiracil (TAS‑102) from patient self-reporting: a multicenter, prospective, observational study
Supportive Care in Cancer
May 2024
Fujii H.
All Open Access, Green
7
Novel therapies for nausea and vomiting in advanced illness and supportive cancer care
Palliative Care and Social Practice
January-December 2024
Davis M.P.
Open Access
8
Dexamethasone-sparing strategies in anthracycline and cyclophosphamide-based chemotherapy with a focus on 5-HT3 receptor antagonists: a network meta-analysis
Frontiers in Oncology
2024
Watanabe D.
Open Access
9
Efficacy and safety of 5HT3RA, DEX, and NK1RA for the prevention of FOLFIRINOX-induced nausea and vomiting in patients with pancreatic cancer: a retrospective cohort study
Supportive Care in Cancer
December 2023
Hishida-Sadaka S.
10
Effect of Mirtazapine for the Prevention of Nausea and Vomiting in Patients With Thoracic Cancer Receiving Platinum-based Chemotherapy
Anticancer Research
March 2023
Kinomura M.
11
12